hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06386939, orgStudyIdInfo id: 01/2024-2025, briefTitle: Comparison of Micro- and Macrovascular Disease(s) in People With T2D, Who Have Moderate to Severe Acanthosis Nigricans vs. Those Who do Not Have Acanthosis Nigricans, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2025-10-30, completionDateStruct date: 2025-11-30, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Diabetes Foundation, India, class: OTHER, collaborators name: National Diabetes Obesity and Cholesterol Foundation, descriptionModule briefSummary: Hypothesis: Moderate to severe acanthosis nigricans in people with T2D is associated with higher magnitude of complication than people who do not have acanthosis nigricans.Objectives: To correlate moderate to severe acanthosis nigricans with diabetes complicationMethodology:T2DM patient will be recruited from endocrine OPD1. Clinical History and Examination:1. General Physical Examination: Height, weight, waist circumference, hip circumference, BMI, Blood Pressure, Hand grip. Acanthosis Nigricans.2. Complications Assessment: Patient will be analysed for:Micro Vascular(a) Diabetic retinopathy (i) Mild NPDR (ii) Mod NPDR (iii) Macular Edema / CSME (b) Neuropathy (Mild/Mod/Severe) (c) Chronic Kidney Disease (i) Micro/Macro albumin urea (ii) Increased Creatinine (iii) Decreased eGFRMacro Vascular1. Low ABI/PAD2. CVD-MI/PTCA/CABG/Heart Failure3. CVS-Stroke/ TIA/Carotid Blockage \>50%, conditionsModule conditions: Type 2 Diabetes Mellitus With Complication, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: OTHER, enrollmentInfo count: 300, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Moderate to Severe Acanthosis Nigricans increases diabetes complications, eligibilityModule sex: ALL, minimumAge: 20 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Anoop misra, status: RECRUITING, city: New Delhi, state: Delhi, zip: 110048, country: India, contacts name: Anoop Misra, MD, role: CONTACT, phone: 01149101222, email: anoopmisra@gmail.com, contacts name: Koel Dutta, M.Sc, role: CONTACT, phone: 01149101222, email: koelduttac@gmail.com, contacts name: Anoop Misra, MD, role: PRINCIPAL_INVESTIGATOR, contacts name: Koel Dutta, M.Sc, role: SUB_INVESTIGATOR, geoPoint lat: 28.63576, lon: 77.22445, hasResults: False
protocolSection identificationModule nctId: NCT06386926, orgStudyIdInfo id: P.T.REC/012/005075, briefTitle: Radial Shockwave Versus Ultrasound Phonophoresis, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2024-07, completionDateStruct date: 2024-09, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: Comparative study to compare the effect of radial shockwave versus ultrasound phonophoresis in management of chronic supraspinatus tendinitis consists of 3 groups exp1(shockwave treatment + conventional physical therapy), exp2( ultrasound phonophoresis+ conventional physical therapy) and control group ( conventional physical therapy), conditionsModule conditions: Supraspinatus Tendinitis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 69, type: ESTIMATED, armsInterventionsModule interventions name: Electro Therapy, outcomesModule primaryOutcomes measure: change in the thickness of supraspinatus tendon, primaryOutcomes measure: change in pain intesity, primaryOutcomes measure: Change in shoulder range of motion, secondaryOutcomes measure: Function of the Upper Limb, secondaryOutcomes measure: measure weight in kg and height in cm, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Cairo university, city: Giza, country: Egypt, contacts name: Shady Alkadry, role: CONTACT, geoPoint lat: 30.00808, lon: 31.21093, hasResults: False
protocolSection identificationModule nctId: NCT06386913, orgStudyIdInfo id: IRB-20-1065, briefTitle: Implementation and Evaluation of Measurement-Based Care (MBC) Training, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2021-02-09, primaryCompletionDateStruct date: 2024-06-30, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Carilion Clinic, class: OTHER, collaborators name: Virginia Polytechnic Institute and State University, descriptionModule briefSummary: The purpose of this study is to get feedback on a new standardized Measurement-Based Care (MBC) provider training program., conditionsModule conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Clinicians completed pre- and post-training surveys. Patient satisfaction was assessed prior to and after clinician training., primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 56, type: ACTUAL, armsInterventionsModule interventions name: Training, outcomesModule primaryOutcomes measure: Digital MBC training rate, primaryOutcomes measure: Assessing feasibility of a novel digital MBC training in mental health providers (FIM), primaryOutcomes measure: Assessing acceptability of a novel digital MBC training program in mental health providers (AIM), primaryOutcomes measure: Assessing appropriateness of a novel digital MBC training program in mental health providers (IAM), otherOutcomes measure: Monitoring and Feedback Attitudes Scale (MFA), otherOutcomes measure: Attitudes Towards Standardized Assessment Scales: Monitoring and Feedback (ASA-MF), otherOutcomes measure: Clinician Attitude and Satisfaction Survey (CASS), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Carilion Clinic, city: Roanoke, state: Virginia, zip: 24014, country: United States, geoPoint lat: 37.27097, lon: -79.94143, hasResults: False
protocolSection identificationModule nctId: NCT06386900, orgStudyIdInfo id: S67595, briefTitle: The Impact of Grand Tour Cycling on Sleep and the Hematological and Metabolomic Profile in World-class Cyclists, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2023-07-01, primaryCompletionDateStruct date: 2024-09-15, completionDateStruct date: 2024-12-01, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: KU Leuven, class: OTHER, descriptionModule briefSummary: This project aims to identify the effect of a 3-week Grand Tour (e.g. Tour de France, Giro d'Italia, and Vuelta a España) on sleep, hematological parameters and the serum metabolome in world-class cyclists., conditionsModule conditions: Overreaching, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 16, type: ESTIMATED, armsInterventionsModule interventions name: Cyclist, outcomesModule primaryOutcomes measure: Serum metabolome abundance of cyclists participating in a Grand Tour, primaryOutcomes measure: Sleep efficiency during the Grand Tour, primaryOutcomes measure: Total sleep time during the Grand Tour, primaryOutcomes measure: Blood haemoglobin concentration, secondaryOutcomes measure: Wakefulness after sleep onset, secondaryOutcomes measure: Light sleep, secondaryOutcomes measure: Deep sleep, secondaryOutcomes measure: REM sleep, secondaryOutcomes measure: Red blood cell concentration, secondaryOutcomes measure: Subjective fatigue, eligibilityModule sex: MALE, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: KU Leuven, city: Leuven, state: Vlaams-Brabant, zip: 3000, country: Belgium, geoPoint lat: 50.87959, lon: 4.70093, hasResults: False
protocolSection identificationModule nctId: NCT06386874, orgStudyIdInfo id: BQ7, briefTitle: [Trial of device that is not approved or cleared by the U.S. FDA], statusModule overallStatus: WITHHELD, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: [Redacted], hasResults: False
protocolSection identificationModule nctId: NCT06386861, orgStudyIdInfo id: 24.210.01e, briefTitle: Validating the Spanish "Attitudes Toward Genomics and Precision Medicine" (AGPM)., statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-14, primaryCompletionDateStruct date: 2024-05-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Boston College, class: OTHER, descriptionModule briefSummary: the investigators aim to evaluate English and Spanish versions of the "Attitudes toward genomics and precision medicine" instrument (AGPM). This study will help validating a Spanish version of the AGPM among people identifying as Hispanic, Latino/a, or Latinx. Having a valid instrument is important for developing tailored interventions to decrease disparities in genomic healthcare for this population., conditionsModule conditions: Adult ALL, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: 500 English-speaking Latinx individuals 500 Spanish-speaking Latinx individuals, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 1000, type: ESTIMATED, armsInterventionsModule interventions name: Attitudes Toward Genomics and Precision Medicine (English), interventions name: Attitudes Toward Genomics and Precision Medicine (Spanish), outcomesModule primaryOutcomes measure: Psychometric properties, secondaryOutcomes measure: Health literacy/numeracy, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Boston College, status: RECRUITING, city: Chestnut Hill, state: Massachusetts, zip: 02467, country: United States, contacts name: Andrew A Dwyer, FNP-BC, PhD, role: CONTACT, phone: 617-552-1711, email: andrew.dwyer@bc.edu, contacts name: Maria Pineros-Leano, PhD, role: SUB_INVESTIGATOR, geoPoint lat: 42.33065, lon: -71.16616, hasResults: False
protocolSection identificationModule nctId: NCT06386848, orgStudyIdInfo id: 2023PI187, briefTitle: Strategy to Adapt Botulinum Toxin Doses in Dystonia, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2024-05-01, completionDateStruct date: 2024-06-01, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Central Hospital, Nancy, France, class: OTHER, descriptionModule briefSummary: The study is designed to observ and collect the doses of botulinum toxin injected in dystonia in different centres to compare the initial dose and the dose recommended.We we ll study the increase of the dose injected over the time, the side effects...The hypothesis is that we inject smaller doses than we could regarding the recommandations, conditionsModule conditions: Dystonia, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Botulinum toxin, outcomesModule primaryOutcomes measure: First dose of botulinum toxin injected, U, secondaryOutcomes measure: Effective dose of botulinum toxin, secondaryOutcomes measure: Side effects, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06386835, orgStudyIdInfo id: CREC2021.724-T, briefTitle: Collagen Paste vs Mucosal Advancement Flap for FIA, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-26, primaryCompletionDateStruct date: 2026-03-31, completionDateStruct date: 2027-03-31, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Chinese University of Hong Kong, class: OTHER, descriptionModule briefSummary: The treatment for fistula-in-ano (FIA) remains a challenge to General and Colorectal Surgeons Worldwide. A variety of surgical treatments have been described for high anal fistulas, but none offers the panacea of fistula eradication with guaranteed preservation of continence. This study compares Collagen paste injection to mucosal advancement flap for the treatment of fistula-in-ano., conditionsModule conditions: Fistula-in-ano, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 118, type: ESTIMATED, armsInterventionsModule interventions name: Collagen Paste, interventions name: Mucosal advancement, outcomesModule primaryOutcomes measure: Clinical healing of Fistula-in-ano, secondaryOutcomes measure: 30-day morbidity, secondaryOutcomes measure: Quality of life score, secondaryOutcomes measure: Postoperative pain score, secondaryOutcomes measure: Faecal incontinence rate, secondaryOutcomes measure: Hospital readmission rate, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Department of Surgery, Chinese University of Hong Kong, status: RECRUITING, city: Shatin, state: New Territories, country: Hong Kong, contacts name: Kaori Futaba, role: CONTACT, email: kfutaba@surgery.cuhk.edu.hk, geoPoint lat: 22.38333, lon: 114.18333, locations facility: Prince of Wlaes Hospital, status: RECRUITING, city: Sha Tin, country: Hong Kong, contacts name: Kaori Futaba, role: CONTACT, phone: 35051495, email: kfutaba@surgery.cuhk.edu.hk, geoPoint lat: 22.38333, lon: 114.18333, hasResults: False
protocolSection identificationModule nctId: NCT06386822, orgStudyIdInfo id: 23-1562H, briefTitle: The Development of a System for the Measurement of Tremor, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-08-01, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: The Bionics Institute of Australia, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to develop a system which can be used to measure movements in people with Essential Tremor (with or without dystonia). The main questions it aims to answer are:* Can individuals with Essential Tremor be distingushed from individuals without tremor using Virtual Reality (VR)* Can the current Essential Tremor Assessment Scale (the TETRAS) be reproduced in VR* Can Essential Tremor be quantified using a measurement system* Can Dystonia be quantified using a measurement system.Participants will don the equipment used to measure their tremor and replicate a series of standardised movements to measure their tremor, in and out of the VR platform. The assessment will take no longer than an hour., conditionsModule conditions: Tremor, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Single group assignment. Up to 90 participants with Essential Tremor and up to 30 Control participants will be recruited to the study. Both groups will undergo the same intervention., primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: HTC Vive Pro Eye, interventions name: HTC Vive Tracker, interventions name: Valve Index Controllers, interventions name: Biokin, outcomesModule primaryOutcomes measure: To quantify Essential Tremor and dystonia using a measurement system, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: The Royal Victorian Eye and Ear Hospital, status: RECRUITING, city: East Melbourne, state: Victoria, zip: 3002, country: Australia, contacts name: Sarah Osborn, BSc, role: CONTACT, phone: 061396677500, email: sosborn@bionicsinstitute.org, geoPoint lat: -37.81667, lon: 144.9879, hasResults: False
protocolSection identificationModule nctId: NCT06386809, orgStudyIdInfo id: 2024 -25, briefTitle: Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation in Bruxism, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2024-08-01, completionDateStruct date: 2024-11-01, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Bandırma Onyedi Eylül University, class: OTHER, descriptionModule briefSummary: Our study aimed to investigate the effects of transcutaneous auricular vagus nerve stimulation (TAVNS) application on treatment efficacy in bruxism in terms of masseter muscle activity, pain, stress level, sleep and life quality, and autonomic functions., conditionsModule conditions: Bruxism, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: TAVNS, interventions name: Exercise program, outcomesModule primaryOutcomes measure: Pain Severity, primaryOutcomes measure: Oral Health Quality of Life, primaryOutcomes measure: Stress Level, primaryOutcomes measure: Sleep Quality, primaryOutcomes measure: Pressure Pain Threshold, primaryOutcomes measure: Muscle Activation Measurement, primaryOutcomes measure: Measurement of heart rate variability/ Autonomic nervous system evaluation, eligibilityModule sex: ALL, minimumAge: 20 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Bandırma Onyedi Eylül University, city: Balıkesir, country: Turkey, geoPoint lat: 39.64917, lon: 27.88611, hasResults: False
protocolSection identificationModule nctId: NCT06386796, orgStudyIdInfo id: Asw.U./867/11/23, briefTitle: Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2025-12-31, completionDateStruct date: 2026-04-01, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Aswan University, class: OTHER, descriptionModule briefSummary: To study the ability of RRI, measured by bedside Doppler ultrasound, in detecting acute kidney injury in high-risk patients admitted to surgical intensive care unit, Aswan university hospital, compared with renal biomarkers and conventional assessment using urine output and serum creatinine levels., conditionsModule conditions: Acute Kidney Injury, conditions: Critical Illness, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 100, type: ESTIMATED, outcomesModule primaryOutcomes measure: Early detection of acute kidney injury., primaryOutcomes measure: Diagnosis of acute kidney injury., secondaryOutcomes measure: To grade the severity of AKI., secondaryOutcomes measure: To predict clinical outcome (clinical improvement), secondaryOutcomes measure: To predict clinical outcome (necessity for renal replacement therapy), secondaryOutcomes measure: To predict clinical outcome (death), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Aswan University, status: RECRUITING, city: Aswan, zip: 81528, country: Egypt, contacts name: Soudy S Hammad, role: CONTACT, phone: +201014761523, email: soudi.salah@aswu.edu.eg, contacts name: Tarek S Hemaida, role: CONTACT, phone: 01007363190, email: dr.tarek@aswu.edu.eg, contacts name: mohamed H Abolwafa, MSc, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 24.09082, lon: 32.89942, hasResults: False
protocolSection identificationModule nctId: NCT06386783, orgStudyIdInfo id: Asw.U./823 /7/23, briefTitle: Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-07-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-07-01, studyFirstPostDateStruct date: 2024-04-26, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Aswan University, class: OTHER, descriptionModule briefSummary: To compare whether 5 μg dexmedetomidine with 25 μg fentanyl added to 0.5% hyperbaric bupivacaine as adjuvants in spinal anaesthesia in patients undergoing appendectomy could reduce intraoperative peritoneal related symptoms., conditionsModule conditions: Dexmedetomidine, conditions: Fentanyl, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: This randomized double blinded study will be conducted at Aswan university hospitals at patients scheduled for emergency appendectomy, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, maskingDescription: concealed based on study drugs assigned to each group \& to conduct this double -blinded clinical trials, our study drugs will be prepared by the senior anesthesiologist who won't be involved in further observations of the patients and neither patients nor outcome assessor will be aware of which drugs they will receive., whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 148, type: ESTIMATED, armsInterventionsModule interventions name: Dexmedetomidine Injection [Precedex], interventions name: Fentanyl HCl, outcomesModule primaryOutcomes measure: intraoperative peritoneal symptoms during appendectomy., secondaryOutcomes measure: Assessment of motor block with Modified Bromage scale, secondaryOutcomes measure: Degree of post-operative analgesia, secondaryOutcomes measure: Assessment of sensory block by using pin prick method, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Aswan University, status: RECRUITING, city: Aswan, zip: 81528, country: Egypt, contacts name: Soudy S Hammad, MD, role: CONTACT, phone: +201014761523, email: soudi.salah@aswu.edu.eg, contacts name: Ahmed M Hagag, MSc, role: CONTACT, phone: 01141097536, contacts name: Ayman M Eldemrdash, MD, role: PRINCIPAL_INVESTIGATOR, contacts name: Ahmed A Mahmoud, MD, role: SUB_INVESTIGATOR, geoPoint lat: 24.09082, lon: 32.89942, hasResults: False